Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1996-10-24
|
pubmed:abstractText |
In this report, we describe the preliminary results from a feasibility and safety study on the clinical use of CD34-positive cells cultured from mobilized peripheral blood. Separation and cell expansion were successfully performed, and the patients tolerated the infusions without problems and achieved engraftment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1061-6128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
527-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8846012-Antigens, CD34,
pubmed-meshheading:8846012-Cell Separation,
pubmed-meshheading:8846012-Cells, Cultured,
pubmed-meshheading:8846012-Female,
pubmed-meshheading:8846012-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:8846012-Hematopoietic Stem Cells,
pubmed-meshheading:8846012-Humans
|
pubmed:year |
1995
|
pubmed:articleTitle |
Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safety.
|
pubmed:affiliation |
University of Chicago Medical Center, IL 60637-1470, USA.
|
pubmed:publicationType |
Journal Article
|